Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis
- PMID: 28196529
- PMCID: PMC5310017
- DOI: 10.1186/s12888-017-1234-1
Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis
Abstract
Background: Systemic lupus erythematosus (SLE) patients are at high risk for depression and anxiety. However, the estimated prevalence of these disorders varies substantially between studies. This systematic review aimed to establish pooled prevalence levels of depression and anxiety among adult SLE patients.
Methods: We systematically reviewed databases including PubMed, Embase, PsycINFO, and the Cochrane database library from their inception to August 2016. Studies presenting data on depression and/or anxiety in adult SLE patients and having a sample size of at least 60 patients were included. A random-effect meta-analysis was conducted on all eligible data.
Results: A total of 59 identified studies matched the inclusion criteria, reporting on a total of 10828 adult SLE patients. Thirty five and thirteen methods of defining depression and anxiety were reported, respectively. Meta-analyses revealed that the prevalence of major depression and anxiety were 24% (95% CI, 16%-31%, I2 = 95.2%) and 37% (95% CI, 12%-63%, I2 = 98.3%) according to clinical interviews. Prevalence estimates of depression were 30% (95% CI, 22%-38%, I2 = 91.6%) for the Hospital Anxiety and Depression Scale with thresholds of 8 and 39% (95% CI, 29%-49%, I2 = 88.2%) for the 21-Item Beck Depression Inventory with thresholds of 14, respectively. The main influence on depression prevalence was the publication years of the studies. In addition, the corresponding pooled prevalence was 40% (95% CI, 30%-49%, I2 = 93.0%) for anxiety according to the Hospital Anxiety and Depression Scale with a cutoff of 8 or more.
Conclusions: The prevalence of depression and anxiety was high in adult SLE patients. It indicated that rheumatologists should screen for depression and anxiety in their patients, and referred them to mental health providers in order to identify effective strategies for preventing and treating depression and anxiety among adult SLE patients.
Trial registration: Current Meta-analysis PROSPERO Registration Number: CRD 42016044125 . Registered 4 August 2016.
Keywords: Anxiety; Depression; Meta-analysis; Systematic review.
Figures
Similar articles
-
Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis.Semin Arthritis Rheum. 2020 Feb;50(1):84-94. doi: 10.1016/j.semarthrit.2019.06.017. Epub 2019 Jun 28. Semin Arthritis Rheum. 2020. PMID: 31303437
-
Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.Rheumatol Int. 2016 Dec;36(12):1705-1710. doi: 10.1007/s00296-016-3559-3. Epub 2016 Aug 31. Rheumatol Int. 2016. PMID: 27580610
-
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms?Lupus. 2014 Nov;23(13):1350-7. doi: 10.1177/0961203314540762. Epub 2014 Jun 18. Lupus. 2014. PMID: 24944187
-
Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis.BMJ Open. 2017 Aug 23;7(8):e017173. doi: 10.1136/bmjopen-2017-017173. BMJ Open. 2017. PMID: 28838903 Free PMC article. Review.
-
Prevalence of depressive symptoms and anxiety in osteoarthritis: a systematic review and meta-analysis.Age Ageing. 2016 Mar;45(2):228-35. doi: 10.1093/ageing/afw001. Epub 2016 Jan 20. Age Ageing. 2016. PMID: 26795974 Review.
Cited by
-
Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review.Lupus Sci Med. 2024 Jul 24;11(2):e001155. doi: 10.1136/lupus-2024-001155. Lupus Sci Med. 2024. PMID: 39053931 Free PMC article. Review.
-
The quality of life of men experiencing infertility: a systematic review.BMC Public Health. 2024 May 5;24(1):1236. doi: 10.1186/s12889-024-18758-6. BMC Public Health. 2024. PMID: 38705989 Free PMC article.
-
Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241246428. doi: 10.1177/17534666241246428. Ther Adv Respir Dis. 2024. PMID: 38676370 Free PMC article.
-
Comorbidities in Privately Insured South Africans With Systemic Lupus Erythematosus.Cureus. 2024 Mar 4;16(3):e55470. doi: 10.7759/cureus.55470. eCollection 2024 Mar. Cureus. 2024. PMID: 38571865 Free PMC article.
-
Psychiatric manifestations of systemic lupus erythematosus: A brief review with two case-reports.SAGE Open Med Case Rep. 2024 Feb 3;12:2050313X241229010. doi: 10.1177/2050313X241229010. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 38313038 Free PMC article.
References
-
- Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, et al. Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2015;33(3):360–5. - PubMed
-
- Kheirandish M, Faezi ST, Paragomi P, Akhlaghi M, Gharibdoost F, Shahali A, et al. Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients. Mod Rheumatol. 2015;25(3):405–9. doi: 10.3109/14397595.2014.962241. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical